MedPath

Comparative study of Glycemic indices between palm sugar and white sugar in healthy Japanese adults

Not Applicable
Conditions
ot applicable (healthy adults)
Registration Number
JPRN-UMIN000023807
Lead Sponsor
InCROM Inc.
Brief Summary

<Results> The conduct of this study was approved by Medical Corporation Heishinkai OPHAC Hospital ERC, and conducted in accordance with the ethical principles of the Declaration of Helsinki and Ethical Guidelines for Medical and Health Research Involving Human Subjects. Prior to the initiation of the study, investigators fully explained about the study to all subjects using the informed consent document approved by the ERC and obtained written informed consent on a voluntary basis. This clinical study started on September 5, 2016 and ended on October 3, 2016. A total of 14 subjects gave written informed consent, and 12 subjects completed the study excluding 2 subjects who discontinued the study because the baseline value of area under the glucose curve was not obtained. The subjects who completed the study were 6 males and 6 females. The means +/- SDs of age, height, weight and BMI of the subjects were 25.5 +/- 2.9 years, 164.13 +/- 9.73 cm, 56.44 +/- 6.67 kg, and 20.93 +/- 0.88. The GI values of the 12 subjects following palm sugar and white intake were similar. The means +/- SDs of GI values after intake of palm sugar and white sugar were 66.35 +/- 16.64 and 69.97 +/- 34.75, respectively. No adverse events occurred in this clinical study. Refer to statistical analysis report for details of statistical analysis results.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria

1. The subject who has hepatic, renal, cardiovascular, respiratory, endocrine system, metabolic, neurological, or psychiatric disorder, or who was assessed to have a past history of any of these diseases by the principal investigator or subinvestigators. 2. The subject who presently has or has a past history of allergic symptoms or hypersensitivity. 3. The subject who is allergic to sugar 4. The subject who has drug or alcohol dependence. 5. In addition, the subject who were assessed ineligible for the study by the principal investigator or subinvestigators.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath